Skip to Content
Merck
  • Choanal atresia associated with prenatal methimazole exposure: three new patients.

Choanal atresia associated with prenatal methimazole exposure: three new patients.

American journal of medical genetics. Part A (2004-07-22)
P Barbero, C Ricagni, G Mercado, R Bronberg, M Torrado
ABSTRACT

We report three patients with bilateral choanal atresia in children prenatally exposed to methimazole (MMI) in order to define a MMI embryopathy clinical pattern. The combination of choanal atresia and other specific malformations strongly resembles previously reported patients exposed to MMI in utero. At present, propylthiouracil is considered the best treatment in pregnancies. However in Argentina and some other countries MMI is the only antithyroid drug, possibly posing a significant risk to the unborn fetus.

MATERIALS
Product Number
Brand
Product Description

Supelco
Methimazole, VETRANAL®, analytical standard
Sigma-Aldrich
2-Mercapto-1-methylimidazole, ≥99%
Supelco
Methimazole, analytical standard
Thiamazole, European Pharmacopoeia (EP) Reference Standard
USP
Methimazole, United States Pharmacopeia (USP) Reference Standard